Fluorescence-based sentinel lymph node mapping and lymphography evaluation: results from the IHU-IRCAD-EAES EURO-FIGS registry
- PMID: 37043006
- DOI: 10.1007/s00464-023-10043-8
Fluorescence-based sentinel lymph node mapping and lymphography evaluation: results from the IHU-IRCAD-EAES EURO-FIGS registry
Abstract
Background: The identification of metastatic lymph nodes is one of the most important prognostic factors in gastrointestinal (GI) cancers. Near-infrared fluorescence (NIRF) imaging has been successfully used in GI tumors to detect the lymphatic pathway and the sentinel lymph node (SLN), facilitating fluorescence image-guided surgery (FIGS) with the purpose to achieve a correct nodal staging. The aim of this study was to analyze the current results of NIRF SLN navigation and lymphography through data collected in the EURO-FIGS registry.
Methods: Prospectively collected data regarding patients and ICG-guided lymphadenectomies were analyzed. Additional analyses were performed to identify predictors of metastatic SLN and determinants of fluorescence positivity and nodal metastases outside the boundaries of standard lymphadenectomies.
Results: Overall, 188 patients were included by 18 surgeons from 10 different centers. Colorectal cancer was the most reported pathology (77.7%), followed by gastric (19.1%) and esophageal tumors (3.2%). ICG was injected with higher doses (p < 0.001) via extraparietal side (63.3%), and with higher volumes (p < 0.001) via endoluminal side (36.7%). Overall, NIRF SLN navigation was positive in 75.5% of all cases and 95.5% of positive SLNs were retrieved, with a metastatic rate of 14.7%. NIRF identification of lymph nodes outside standard lymphatic stations occurred in 52.1% of all cases, 43.8% of which were positive for metastatic involvement. Positive NIRF SLN identification was an independent predictor of metastasis outside standard lymphatic stations (OR = 4.392, p = 0.029), while BMI independently predicted metastasis in retrieved SLNs (OR = 1.187, p = 0.013). Lower doses of ICG were protective against NIRF identification outside standard of care lymphadenectomy (OR = 0.596, p = 0.006), while higher volumes of ICG were predictive of metastatic involvement outside standard of care lymphadenectomy (OR = 1.597, p = 0.001).
Conclusions: SLN mapping helps identifying potentially metastatic lymph nodes outside the boundaries of standard lymphadenectomies. The EURO-FIGS registry is a valuable tool to share and analyze European surgeons' practices.
Keywords: Colorectal cancer; EURO-FIGS; Fluorescence-guided surgery; Near-infrared fluorescence imaging; Sentinel lymph node mapping.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Benson AB, Venook AP, Al-Hawary MM et al (2018) Nccn guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw 16(4):359–369. https://doi.org/10.6004/jnccn.2018.0021 - DOI - PubMed - PMC
-
- Ajani JA, D’Amico TA, Almhanna K et al (2016) Gastric cancer, version 3.2016, nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw 14(10):1286–1312. https://doi.org/10.6004/jnccn.2016.0137 - DOI - PubMed
-
- Wiese D, Sirop S, Yestrepsky B et al (2010) Ultrastaging of sentinel lymph nodes (slns) vs. Non-slns in colorectal cancer–do we need both? Am J Surg. https://doi.org/10.1016/j.amjsurg.2009.08.032 - DOI - PubMed
-
- Mitsumori N, Nimura H, Takahashi N et al (2014) Sentinel lymph node navigation surgery for early stage gastric cancer. World J Gastroenterol 20(19):5685–5693. https://doi.org/10.3748/wjg.v20.i19.5685 - DOI - PubMed - PMC
-
- van der Pas MH, Meijer S, Hoekstra OS et al (2011) Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol 12(6):540–550. https://doi.org/10.1016/S1470-2045(11)70075-4 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
